search
Back to results

Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors

Primary Purpose

Insomnia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SHUTi
Sponsored by
Dana-Farber Cancer Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Insomnia focused on measuring Insomnia

Eligibility Criteria

14 Years - 25 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 14-25 years of age
  • History of a cancer diagnosis
  • No active cancer therapy (excluding chemoprevention) in the past three months, and no cancer therapy currently planned in the next 6 months
  • No surgery planned in the next 6 months
  • Significant insomnia as evidenced by an Insomnia Severity Index score ≥12
  • Able to read and write in English
  • Has internet access at home
  • Motivated and able to follow the demands of the SHUTi program, to keep sleep records, complete self-report symptom reports and make changes in their sleep schedule, including restricting their sleep

Exclusion Criteria:

  • Prior attempt(s) to treat insomnia using cognitive-behavioral treatment for insomnia
  • History of Bipolar Disorder diagnosis
  • History of a Seizure Disorder diagnosis or have experienced a seizure in the past 12 months
  • Intention to adjust (decrease or increase) use of sedative, hypnotic, or over-the-counter (e.g., Benadryl, Unisom) medications that can affect sleep during the study period
  • Diagnosed, untreated sleep apnea or sleep apnea suspected by a physician but which has not been unevaluated, or other sleep disorder
  • Employment that involves irregular sleep patterns, such as shift-work or frequent long-distance travel that involves adjusting to different time zones, or employment in a position that could impact public safety (such as operating heavy machinery)
  • Refusal to modify or reduce excessive alcohol use that is likely to interfere with an individual's sleep

Sites / Locations

  • Dana-Farber Cancer Institute

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

SHUTi

Arm Description

Participants will be provided with an individual access code for SHUTi SHUTi is delivered over 6 sessions, each taking 20-30 minutes SHUTi is delivered by a virtual therapist Participants will learn about the etiology and maintenance of their insomnia Participants will learn how to maintain their sleep log Participants will learn how to address lifestyle barriers that impact their sleep Participants will be taught stimulus control techniques targeting non-sleep behaviors in the bedroom Participants will learn a range of cognitive techniques that address the key cognitive factors that perpetuate poor sleep behavior Participants will be taught how to gradually expand their restricted sleep

Outcomes

Primary Outcome Measures

Insomnia symptoms
Insomnia symptom severity will be assessed using the Insomnia Severity Index

Secondary Outcome Measures

Sleep efficiency
Sleep diary calculated sleep efficiency
Quality of life
Measured with PedsQL
Daytime sleepiness
Measured with Pediatric Daytime Sleepiness Scale

Full Information

First Posted
September 9, 2017
Last Updated
October 27, 2020
Sponsor
Dana-Farber Cancer Institute
Collaborators
Alex's Lemonade Stand Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT03279055
Brief Title
Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors
Official Title
Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
August 10, 2018 (Actual)
Primary Completion Date
December 20, 2019 (Actual)
Study Completion Date
December 20, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Dana-Farber Cancer Institute
Collaborators
Alex's Lemonade Stand Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This research study is evaluating a six-session online program designed to help insomnia (difficulty falling or staying asleep) in adolescent and young adult cancer survivors.
Detailed Description
The purpose of this study is to learn whether an adapted version of SHUTi (Sleep Healthy Using the Internet), a six-session online program which has been found to be effective in other groups of people, will be useful in treating insomnia in adolescent and young adult cancer survivors.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia
Keywords
Insomnia

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SHUTi
Arm Type
Experimental
Arm Description
Participants will be provided with an individual access code for SHUTi SHUTi is delivered over 6 sessions, each taking 20-30 minutes SHUTi is delivered by a virtual therapist Participants will learn about the etiology and maintenance of their insomnia Participants will learn how to maintain their sleep log Participants will learn how to address lifestyle barriers that impact their sleep Participants will be taught stimulus control techniques targeting non-sleep behaviors in the bedroom Participants will learn a range of cognitive techniques that address the key cognitive factors that perpetuate poor sleep behavior Participants will be taught how to gradually expand their restricted sleep
Intervention Type
Behavioral
Intervention Name(s)
SHUTi
Intervention Description
Sleep Healthy Using the Internet (SHUTi) is a publicly available insomnia intervention program. It focuses on 5 treatment components that form the core of CBT-I: sleep restriction, stimulus control, cognitive restructuring, sleep behaviors, and relapse prevention.
Primary Outcome Measure Information:
Title
Insomnia symptoms
Description
Insomnia symptom severity will be assessed using the Insomnia Severity Index
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Sleep efficiency
Description
Sleep diary calculated sleep efficiency
Time Frame
6 weeks
Title
Quality of life
Description
Measured with PedsQL
Time Frame
8 weeks
Title
Daytime sleepiness
Description
Measured with Pediatric Daytime Sleepiness Scale
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 14-25 years of age History of a cancer diagnosis No active cancer therapy (excluding chemoprevention) in the past three months, and no cancer therapy currently planned in the next 6 months No surgery planned in the next 6 months Significant insomnia as evidenced by an Insomnia Severity Index score ≥12 Able to read and write in English Has internet access at home Motivated and able to follow the demands of the SHUTi program, to keep sleep records, complete self-report symptom reports and make changes in their sleep schedule, including restricting their sleep Exclusion Criteria: Prior attempt(s) to treat insomnia using cognitive-behavioral treatment for insomnia History of Bipolar Disorder diagnosis History of a Seizure Disorder diagnosis or have experienced a seizure in the past 12 months Intention to adjust (decrease or increase) use of sedative, hypnotic, or over-the-counter (e.g., Benadryl, Unisom) medications that can affect sleep during the study period Diagnosed, untreated sleep apnea or sleep apnea suspected by a physician but which has not been unevaluated, or other sleep disorder Employment that involves irregular sleep patterns, such as shift-work or frequent long-distance travel that involves adjusting to different time zones, or employment in a position that could impact public safety (such as operating heavy machinery) Refusal to modify or reduce excessive alcohol use that is likely to interfere with an individual's sleep
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric Zhou, PhD
Organizational Affiliation
Dana-Farber Cancer Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dana-Farber Cancer Institute
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32568460
Citation
Zhou ES, Recklitis CJ. Internet-delivered insomnia intervention improves sleep and quality of life for adolescent and young adult cancer survivors. Pediatr Blood Cancer. 2020 Sep;67(9):e28506. doi: 10.1002/pbc.28506. Epub 2020 Jun 22.
Results Reference
result

Learn more about this trial

Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors

We'll reach out to this number within 24 hrs